Expressive Writing Program Among Young Adults With Blood Cancer

NCT07413991 | Recruiting

• 1 other identifier: BCU26-01
• Study Type: interventional
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this study is to learn more about an expressive writing workshop among people with blood cancer. The main question it aims to answer is whether and how an expressive writing workshop can impact mental wellness. Participants will

• Take part in an online expressive writing workshop for four weeks
• Take three surveys at different times over 12 weeks Researchers will compare changes in mental wellness reported by the participants of the workshop to those who will wait four weeks to start the workshop. After four weeks, the participants who are waiting will start their workshop.

Conditions

Hematologic Malignancy

Keywords

expressive writing

Outcome Measures

Primary Outcomes (2)

• Mental Wellbeing

  Participants' mental wellbeing will be evaluated using the Warwick Edinburgh Mental Wellbeing Scale (WEMWBS), specifically the original 14-item scale developed by researchers at the University of Warwick and the University of Edinburgh in 2007. This self-report questionnaire asks questions about participants' feelings and how they have been functioning over the last two weeks to capture a comprehensive view of their recent mental wellbeing. Participants will rate each question on a 5-point Likert scale, and their responses will be totaled to a mental wellbeing score ranging from 14-70; higher scores indicate greater wellbeing.

  Baseline, 4, and 8 weeks

• Perceived Stress

  A self-report questionnaire captures whether participants perceive different life situations as overwhelming or uncontrollable. Participants will rate each question on a 5-point Likert scale, and their responses will be totaled to a stress score ranging from 0-40, with higher score indicated more perceived stress.

  Baseline, 4, and 8 weeks

Study Arms (2)

Group 1

EXPERIMENTAL

Primary Intervention Group

Behavioral: Expressive Writing Workshop

Group 2

PLACEBO COMPARATOR

Wait List Control Group

Behavioral: Expressive Writing Workshop

Interventions

Expressive Writing Workshop BEHAVIORAL

Group 1 will start the workshop the following week. Group 2 will wait 4 weeks before starting the workshop. There is an equal chance of being placed group 1 or group 2. You cannot choose your study group. The workshop is the same for both groups.

Group 1; Group 2

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patient with a hematologic malignancy diagnosis in treatment or after treatment is completed, who is currently between the ages of 18 and 39 (young adult), or the informal caregiver of a young adult blood cancer patient
• Located within the U.S., Canada, or U.S. territories
• Able to read and write in English

You may not qualify if:

• Located outside of the U.S., Canada, or its territories
• Participant is a minor aged 17 years or below

Sponsors & Collaborators

• Blood Cancer United: lead

Study Sites (1)

Blood Cancer United

Washington D.C., District of Columbia, 20005, United States

RECRUITING

MeSH Terms

Conditions

Hematologic Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases

Central Study Contacts

Research Coordinator

CONTACT

914-821-8862; researchprograms@bloodcancerunited.org

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 10, 2026
• First Posted: February 17, 2026
• Study Start: February 1, 2026
• Primary Completion (Estimated): September 30, 2026
• Study Completion (Estimated): September 30, 2026
• Last Updated: May 7, 2026

Record last verified: 2026-02

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)